|
|
||||||||
Ann Thorac Surg 2005;79:776-782
© 2005 The Society of Thoracic Surgeons
Cardiac Surgical Associates, PA, St. Paul, Minnesota
Accepted for publication August 23, 2004.
* Address reprint requests to Dr Emery, Cardiac Surgical Associates, PA, 2356 University Avenue West, Suite 258, St. Paul, MN 55114; (E-mail: dremery{at}csa-heart.com).
BACKGROUND: From October 1977 to October 2002, 4,480 patients (age range, 17 to 94 years; average, 64 ± 13 years) underwent single valve replacement with the St. Jude Medical heart valve. Of 2,982 aortic (AVR) and 1,498 mitral valve replacements (MVR), concomitant coronary artery bypass grafting was performed on 42% and 33%, respectively.
METHODS: Cardiac Surgical Associates has maintained an independent database of patients having valve replacement with the St. Jude Medical prosthesis since the world's first implant. Patients were contacted by questionnaire or phone from November 2002 through June 2003. Hospital course and valve-related events were verified by patient chart review or physician contact.
RESULTS: Follow-up was 95% complete. Operative mortality was 4% with AVR and 9% with MVR. Total follow-up was 32,190 patient-years (range, 1 month to 24.8 years; average, 7 ± 5 years). During the study period, patient freedom from late mortality was 61% (AVR, 61%; MVR, 63%), and from valve-related mortality 92% (AVR, 93%; MVR, 91%). Freedom from thromboembolic events was 85% (86% AVR, 81% MVR), from bleeding events, 81% (81% AVR, 81% MVR), from reoperation, 98% (99% AVR, 97% MVR), from endocarditis, 98% (99% AVR, 98% MVR), and from valve thrombosis, 99% (99% AVR, 98% MVR). There was one MVR structural failure (0.06%).
CONCLUSIONS: The St. Jude Medical valve has proven to be an effective and durable valve prosthesis with a low event rate during the long term.
Related Article
Ann. Thorac. Surg. 2005 79: 782-783.
This article has been cited by other articles:
![]() |
S. H. McKellar, J. L. Thompson III, R. F. Garcia-Rinaldi, R. J. MacDonald, T. M. Sundt III, and H. V. Schaff Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 908 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Eichinger, I. M. Hettich, D. J. Ruzicka, K. Holper, C. Schricker, S. Bleiziffer, and R. Lange Twenty-year experience with the st. Jude medical biocor bioprosthesis in the aortic position. Ann. Thorac. Surg., October 1, 2008; 86(4): 1204 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Thompson, T. M. Sundt, M. E. Sarano, P. J. Santrach, and H. V. Schaff In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation. Ann. Thorac. Surg., June 1, 2008; 85(6): 2046 - 2050. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A.C. Ennker, A. A. Albert, U. P. Rosendahl, I. C. Ennker, F. Dalladaku, and I. Florath Ten-Year Experience With Stentless Aortic Valves: Full-Root Versus Subcoronary Implantation Ann. Thorac. Surg., February 1, 2008; 85(2): 445 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Emery, A. M. Emery, A. Knutsen, and G. V. Raikar Aortic Valve Replacement with a Mechanical Cardiac Valve Prosthesis Card. Surg. Adult, January 1, 2008; 3(2008): 841 - 856. [Full Text] |
||||
![]() |
T. E. David Surgical Treatment of Aortic Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 949 - 956. [Full Text] |
||||
![]() |
T. Gudbjartsson, T. Absi, and S. Aranki Mitral Valve Replacement Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068. [Full Text] |
||||
![]() |
J. L. Svennevig, M. Abdelnoor, and S. Nitter-Hauge Twenty-Five Year Experience With the Medtronic-Hall Valve Prosthesis in the Aortic Position: A Follow-Up Cohort Study of 816 Consecutive Patients Circulation, October 16, 2007; 116(16): 1795 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bakhtiary, O. Dzemali, U. Steinseiffer, C. Schmitz, B. Glasmacher, A. Moritz, and P. Kleine Opening and closing kinematics of fresh and calcified aortic valve prostheses: An in vitro study J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Verhoye, I. Abouliatim, B. Lelong, A. Ingels, X. Roques, J. Pierre Villemot, T. Langanay, and A. Leguerrier Edwards Mira bileaflet prosthesis in aortic position: midterm results of a prospective multi-centre study Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 458 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Q. Han, Z.-Y. Xu, B.-R. Zhang, L.-J. Zou, J.-H. Hao, and S.-D. Huang Primary triple valve surgery for advanced rheumatic heart disease in Mainland China: a single-center experience with 871 clinical cases Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 845 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David, G. Gavra, C. M. Feindel, T. Regesta, S. Armstrong, and M. D. Maganti Surgical treatment of active infective endocarditis: A continued challenge J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 144 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, V. Rao, M. A. Borger, M. Maganti, S. Armstrong, C. M. Feindel, H. E. Scully, and T. E. David Short- and Long-Term Results of Triple Valve Surgery in the Modern Era Ann. Thorac. Surg., June 1, 2006; 81(6): 2172 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
St Jude Medical Regent valve. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 760 - 761. |
||||
![]() |
R. Garcia-Rinaldi Clopidogrel-Aspirin Inhibit the Thrombogenicity of St. Jude Mechanical Aortic Prostheses Ann. Thorac. Surg., February 1, 2006; 81(2): 787 - 787. [Full Text] [PDF] |
||||
![]() |
R. W. Emery and A. M. Emery Reply Ann. Thorac. Surg., February 1, 2006; 81(2): 788 - 788. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |